Industry NewsCBD, the latest wellness craze, won’t cause users to fail a drug test—but its lesser known cousin CBN will
Industry NewsEisai's Anticancer Agent Halaven Approved for Treatment of Locally Advanced or Metastatic Breast Cancer in China
Industry NewsCRISPR Therapeutics and ProBioGen Collaborate to Develop Novel In Vivo Delivery Technologies